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Abstract
To clarify E1^E4’s role during high-risk HPV infection, the E4 proteins of HPV16 and 18
were compared side by side using an isogenic keratinocyte differentiation model. While no
effect on cell proliferation or viral genome copy number was observed during the early
phase of either virus life cycle, time-course experiments showed that viral genome amplifi-
cation and L1 expression were differently affected upon differentiation, with HPV16 showing
a much clearer E4 dependency. Although E4 loss never completely abolished genome
amplification, its more obvious contribution in HPV16 focused our efforts on 16E4. As previ-
ously suggested, in the context of the virus life cycle, 16E4s G2-arrest capability was found
to contribute to both genome amplification success and L1 accumulation. Loss of 16E4 also
lead to a reduced maintenance of ERK, JNK and p38MAPK activity throughout the genome
amplifying cell layers, with 16E4 (but not 18E4) co-localizing precisely with activated cyto-
plasmic JNK in both wild type raft tissue, and HPV16-induced patient biopsy tissue. When
16E1 was co-expressed with E4, as occurs during genome amplification in vivo, the E1
replication helicase accumulated preferentially in the nucleus, and in transient replication
assays, E4 stimulated viral genome amplification. Interestingly, a 16E1 mutant deficient in
its regulatory phosphorylation sites no longer accumulated in the nucleus following E4 co-
expression. E4-mediated stabilisation of 16E2 was also apparent, with E2 levels declining in
organotypic raft culture when 16E4 was absent. These results suggest that 16E4-mediated
enhancement of genome amplification involves its cell cycle inhibition and cellular kinase
activation functions, with E4 modifying the activity and function of viral replication proteins
including E1. These activities of 16E4, and the different kinase patterns seen here with
HPV18, 31 and 45, may reflect natural differences in the biology and tropisms of these
viruses, as well as differences in E4 function.
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Author summary
In HPV induced lesions, the most abundant protein expressed in the productive stage of
viral life cycle is E1^E4 (E4), with its expression being coincident with viral genome
amplification. To clarify the role of E4 in the high-risk HPV life cycle, we carried out a
comparative analysis of E4 function in HPV16 and 18 using an isogenic keratinocyte cell-
line background. Our results show that E1^E4 contributes to virus genome replication
efficiency and life cycle completion rather than being essential. These effects were seen
more dramatically with HPV16. The difference between HPV16 and HPV18 in our sys-
tem suggests important tropism differences between these viruses. HPV16 E4’s contribu-
tion to the virus life cycle is mediated by several activities, including its G2 arrest function,
as well as its role in activating members of the MAPK pathway, including ERK, p38, and
most notably pJNK. These 16 E4 functions facilitated the nuclear localization of the E1
virus helicase and enhanced E1/E2 dependent viral genome amplification as well as stabi-
lising E2. We suspect that the massive accumulation of E4 in the upper epithelial layers
may however underlie a more critical role for E4 post-genome amplification.
Introduction
Human papillomaviruses (HPVs) are small, non-enveloped DNA viruses that infect cutaneous
and mucosal stratified epithelium to induce a wide variety of epithelial lesions ranging from
benign papillomas to invasive carcinomas [1]. So far, more than one hundred and fifty HPV
types have been completely sequenced [2], with anogenital types being divided into two groups
according to their contribution to cancer development. The low-risk types include HPV 6
and 11 that are associated primarily with benign genital lesions. The high-risk types, such as
HPV16, 18, 31, 33, and 45 are found in around 99.7% of cervical cancers, with HPV types 16
and 18 being responsible for more than 75% of cervical cancers worldwide [3]. Although both
HPV16 and 18 are contained within the Alpha Papillomavirus Genus, they are members of dif-
ferent species (Alpha7 and 9), with different biologies and disease-associations. For all papillo-
maviruses, the virus life cycle is linked to the differentiation of the infected epithelial cell as it
migrates from the basal layer to the epithelial surface. Viral genomes are maintained as nuclear
episomes that replicate along with cellular DNA at low copy number in the basal layer. Follow-
ing cell division, HPV genomes partition into the two daughter cells, with one of these entering
the suprabasal layers and committing to terminal differentiation. Although this facilitates
expression of L1 and L2 and the assembly of infectious virions, completion of the virus life
cycle depends on epithelial site of infection, with life-cycle deregulation leading to neoplasia,
and in some instances, the development of cancer [1, 4, 5].
During the HPV life cycle, levels of the viral E1^E4 protein rise as genome amplification
begins, allowing accumulation of E4 protein in the upper layer of the epithelium in cells sup-
porting virus synthesis. The E1^E4 protein is translated from a spliced mRNA, with the first
5 amino acids being encoded by the E1 open reading frame [6–8]. The E1^E4 protein associ-
ates with and reorganizes the cellular cytokeratin network both in vivo and in vitro via its
N-terminal leucine-rich motif (LLXLL), which may eventually contribute to efficient virus
release [9–12]. Recent findings suggest that this interaction may also affect viral genome ampli-
fication, with the disruption of the HPV16 E1^E4 keratin binding motif leading to a defect in
amplification success during the virus life cycle [13]. Interestingly, over-expression of the E4
protein of HPV1, 16 and 18 in monolayer cell culture induces a robust G2/M cell cycle arrest
[14–17], which may create an environment that facilitates efficient E6/E7 driven viral genome
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amplification. In HPV16, an association of E1^E4 with Cdk1/cyclinB complexes via its PTTP
motif is responsible for this effect [15]. Our recent work suggests a further complexity of
E1^E4 function, with the protein being modified first by MAPK and then by Cdk1/cyclinB
[14, 18] as the infected cell moves from S-phase into G2 prior to growth arrest. These changes
modify E4 structure and keratin association, and eventually facilitate E1^E4 cleavage by the
protease calpain. This final post-translational modification removes key sequences at the pro-
teins N-terminus, allowing it to multimerise and to be deposited as highly abundant amyloid
fibrils [19]. This ordered pattern of expression and protein modification suggests a primary
role for E4 in the productive stages of the virus life cycle, including genome amplification,
virus assembly, virus transmission and release. Recent data from several groups have suggested
a role for E1^E4 in genome amplification and life cycle completion. However, there appear to
be significant differences between its roles in different HPV types and when function is exam-
ined in different cell backgrounds. Whereas in HPV18 and 31, loss of full length E1^E4 protein
led to impaired genome amplification when analysed in human primary foreskin keratinocytes
[20, 21], in HPV 11, the truncated E1^E4 has been reported not to compromise life cycle com-
pletion, which was examined in N-Tert cells, a human foreskin keratinocyte line immortalized
by hTERT (the catalytic subunit of human telomerase) [22]. In HPV16, our previous work
showed different effects depending on the length of the E4 protein following expression in
NIKS, a spontaneously immortalised human keratinocyte cell line [13]. Taken together, the
precise contribution of E1^E4, and the mechanism by which it acts to optimize genome ampli-
fication have yet to be firmly established. These varying results do however suggest that E4
may not have precisely the same function in all papillomaviruses, and that this may differ even
between members of the high-risk HPV group, mirroring the differences in the functions of
other high-risk HPV gene products such as E6 and E7.
To define E4’s role in the virus life cycle more methodically, we have examined its function
in the context of the two most important HPV types (HPV16 and 18) during their full produc-
tive life cycle. We have taken care to overcome issues relating to keratinocyte batch-variation
and/or protocols by using a common cell background (i.e. the isogenic NIKS keratinocyte cell-
line), and an optimized organotypic raft culture approach that robustly support the life cycle of
a diverse range of HPV types including HPV16 [23, 24]. NIKS (Near-diploid Immortalised
KeratinicyteS) is a pathogen-free, immortal human keratinocyte progenitor, that provides a
reliable and reproducible model system for the study of epithelial keratinocyte growth and dif-
ferentiation [25], and the papillomavirus life cycle [26]. Indeed, NIKS epithelium ‘STRATA-
GRAFT’, is currently being developed by STRATATECH, and is being tested in Phase 3 trials
as a temporary skin replacement for burns victims (http://www.stratatechcorp.com/). Based
on these systems, we have carried out a comparative functional analysis using genomic
mutants, and have in addition made extensive use of time-course experiments to discriminate
between loss of function and functional delay in the organotypic raft system. It appears from
this that E1^E4 contributes to virus replication efficiency and life cycle completion, rather
than being essential for these events, with HPV16 E1^E4 having a much more dramatic contri-
bution when direct comparisons are made in common genetic background. This may be
linked to the greater propensity of HPV16 to drive neoplasia at stratified epithelial sites, and
thus the greater role for E1^E4 in arresting cell cycle progression in a G2-like state during the
late stages of infection. The additional novel observation, that 16E1^E4 prominently sequesters
active JNK kinase, and other members of the MAPK family in the cytoplasm during the pro-
ductive phases of the virus life cycle, provides an additional role of E4 in enhancing the accu-
mulation of the viral E1 helicase in the nucleus. It is clear from this, that 16 E4 contributes to
genome amplification success through several molecular mechanisms, and that the extent of
E4’s contribution differs even amongst the high-risk HPV group.
Differential life-cycle roles for HPV16 and 18 E4
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Materials and methods
Ethics statement
The collection of clinical material used in this study complied with the Helsinki Declaration of
1975, as revised in 1983 as described previously [29]. All tissue sections were obtained as part
of a study with Jagiellonian University, Krakow Poland [29], with sample collection being
approved by the relevant Ethical Review Board (IRB nr KBET/2/B/2010 dated 07.01.2010). All
patients participating in that study were adults and gave written informed consent prior to sur-
gery. All experiments using human tissue are licenced at University of Cambridge by Human
Tissue Authority (Licensing number 12196).
Cell culture and collection of clinical samples
C33a (ATCC), SiHa (ATCC, a cervical carcinoma cell line that constitutively expresses HPV16
E6 and E7), 293T (ATCC) were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM,
SIGMA) supplemented with 10% fetal calf serum (FCS, HyClone) and 1% penicillin and strep-
tomycin. NIKS (a gift from Paul Lambert, McArdle Laboratory for Cancer Research, Univer-
sity of Wisconsin), a HPV-negative spontaneously immortalised human keratinocyte cell line,
was maintained at sub-confluence on γ-Irradiated J2 3T3 feeder cells (a gift from Paul Lam-
bert) in F medium with all supplements as previously described [27, 28]. All cells were incu-
bated at 37˚C in a 5% CO2 environment.
Plasmid construction and site-directed mutagenesis
To construct the HPV18 E4 genomic mutant, a subgenomic HPV18 fragment was excised
from plasmid pBSSK-HPV18 (pBSSK-HPV18 was a gift from Craig Meyers, the Pennsylvania
State University College of Medicine [30]) by digestion with ApaI, which cleaves at position
663 on pBSSK, and at nucleotide 4535 in the HPV18 genome. This fragment, which contains
the E4 ORF, was subcloned into pBC (Stratagene, The Netherlands) and used as a template for
PCR-mediated, site-directed mutagenesis (QuickChange XL Site-Direct Mutagenesis system,
Stratagene, The Netherlands). Two nucleotide substitutions (T3467 to A and T3470 to A) were
inserted into the E4 ORF using the forward primer 5’-TAT CCG CTA CTC AGC TAG TAA
AAC AGC TAC AGC ACA CCC-3’ and reverse primer 5’GGG TGT GCT GTA GCT GTT
TTA CTA GCT GAG TAG CGG ATA-3’. These changes introduced a translational stop
codon into E4, with only a silent change in the overlapping E2 coding sequence. After muta-
genesis, the subgenomic fragment was cloned back into pBS-HPV18, and the entire HPV18
genome was sequenced to confirm that the genome contained only the desired mutations. The
construction of E4 mutant HPV16 genome (16st15) was described previously [13]. To generate
the G2 arrest mutant of HPV16E1^E4, the same W12 strain of the HPV genome (originally
cloned into the pSp64 vector, a kind gift from Prof. Margaret Stanley, Department of Virology,
University of Cambridge) was cloned into the BamHI site of the modified plasmid pTZh19U
(pTZhW12 HPV16 [31].Mutagenesis was performed by PCR-based site-directed mutagenesis
as described above (QuickChange XL Site-Directed Mutagenesis system, Stratagene, The
Netherlands) using primers AGGCAGCACTTGGCCAATCATTCCGCCGCG and CGCGGC
GGAATGATTGGCCAAGTGCTGCCT in order to generate a mutant genome with changes
in the 16E1^E4 region necessary for G2-arrest motif. Both wild type (WT) and mutant (T22I,
T23I) genomes were sequenced to ensure that no additional base changes were present. The
pDrive-GAPDH plasmid used for copy-number evaluation was prepared by cloning a 361
bp fragment of human GAPDH (Genbank accession NM-002046) into pDrive (Qiagen Ltd,
UK) after amplification by RT-PCR from total RNA extracted from NIKS (forward primer
Differential life-cycle roles for HPV16 and 18 E4
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GCCTCCCGCTTCGCTCTC and reverse primer GCCAGCATCGCCCCACTTG). RNA iso-
lation and RT-PCR were described previously [18]. To construct the E1/E2/E4 expression vec-
tor (pIRES-E1E2E4), the region of HPV16 containing the E1, E2 and E4 open-reading frames
(ORFs) was amplified from the HPV16 WT and E4KO genome by PCR amplification using
primers ACG TGA ATT CTA ATC TAC CAT GGC TGA TCC TGC AGG TAC CAA T and
ACG TTC TAG ACG CGG ATC CTC ATA TAG ACA TAA ATC CAG TAG A. The ampli-
fied DNA fragments were cloned into the pIRESeGFP (pIRES) vector (Clontech) utilising the
EcoRI and BamHI restriction enzyme sites to create plasmids pIRES-E1E2E4 and pIRES-E1E2.
The HPV16 origin-containing reporter plasmid (p16Ori-CMV-Gluc) was prepared from
pCMV-Gluc2 (New England Biolabs, NEB) by cloning a PCR-amplified HPV16 LCR fragment
(nt positions 7267–103) in reverse orientation as shown diagrammatically in S6 Fig (primer
sequences available upon request). Ligation was carried out using an In-Fusion Cloning Kit
(Clontech) according to the manufacturer’s instructions.
Generation of NIKS cell lines containing HPV genomes and propagation
in organotypic raft culture
Plasmids containing HPV16 and HPV18 genomes (wild type or mutant) were digested with
BamHI (HPV16) or EcoRI (HPV18) to release the whole viral genome. The linearized HPV16
or HPV18 genomes were then re-circularized and purified as described previously, before
being co-transfected with a plasmid encoding blastocidin into NIKS cells [32]. Twenty-four
hours later, NIKS cells were selected with 6 μg/ml blasticidin for 5–7 days, and after screening
by PCR and Southern blotting, isogenic WT and E4KO pairs of HPV16 or HPV18 populations
with similar viral genomic copy number/cell were used for comparative analysis in organoty-
pic raft cultures as described by Isaacson et al [23, 24, 32].
Differentiation of keratinocytes in semisolid medium
Prior to differentiation, NIKS cells were prepared from monolayer cultures following trypsini-
zation, and suspended in 1.5% methylcellulose as previously described [33]. Approximately
4 x 106 keratinocytes were plated into a total of 6 ml methylcellulose medium in 6 wells of a
24-well plate and incubated at 37˚C in a CO2-containing humidified incubator for 24–72 h.
Cells were washed 5 times by centrifugation in ice-cold PBS and re-suspended in 100 μl Qiagen
ATL buffer before DNA preparation using the QIAamp DNA Micro Kit (Qiagen, UK).
Detection and quantification of DNA
Real-time PCR was used for the detection and quantification of HPV DNA and human
GAPDH using the primers and TaqMan probes shown in Table 1. Reactions were prepared in
a volume of 25μl containing either 1×TaqMan Universal PCR Mastermix (Applied Biosystems
Ltd, UK), 2.5mM of each primer and 6.25mM TaqMan probe, or containing 1× Absolute
SYBR Green QPCR Rox Mix (Applied Biosystems Ltd, UK) with 70nM of each primer. PCR
was performed using an ABIprism 7500 system with 15 min denaturation at 95˚C followed by
40 cycles of 95˚C for 15s and 60˚C for 60s. For each real-time PCR assay, a standard curve
experiment was performed to allow absolute quantification of DNA. For HPV genomic DNA,
pTZhW12HPV16 or pBSHPV18 were used as templates, and for human GAPDH, pDrive-
GAPDH was used as template. Serial dilutions of plasmid DNA were prepared to allow DNA
copy number to be plotted against cycle threshold value. All real-time PCR reactions were run
in triplicate alongside no-template controls. To quantitate HPV DNA levels in HPV genome-
containing cell populations and cell lines, HPV copy number per cell was expressed relative to
GAPDH copy number. The human genome blast using designed primers and probe for
Differential life-cycle roles for HPV16 and 18 E4
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human GAPDH shown in Table 1 indicated that there are 4 copies, comprising 2 copies of
GAPDH and 2 pseudogene copies of GAPDH per NIKS cell. This was confirmed by determi-
nation of GAPDH copy number against known NIKS cell number.
Fluorescence in situ hybridization (FISH)
Slides of formalin fixed, paraffin embedded raft tissue were baked and de-paraffinised by
washing three times in xylene followed by two washes in 100% ethanol. The slides were then
rehydrated in 80%, 50% and 30% ethanol for two minutes each, and then finally in PBS for 5
minutes. Sections were then heated in 0.01M citric acid (pH 6.0) in microwave for 2 minutes,
prior to protein digestion with Digest All 3 pepsin (Zymed) at 37˚C for 10 seconds. HPV16 or
18 DNA was labelled with digoxigenin by use of the DIG DNA labeling Kit (Roche Applied
Science Gmbh, Germany) according to the manufacturer’s instructions. DIG-Labeled HPV
DNA was added to slides, denatured for 5 min at 76˚C, and incubated overnight at 42˚C. After
washing, the DIG-positive HPV probe was detected with an anti-digoxigenin-POD antibody
at 1:400 (Roche Applied Science Gmbh, Germany) and the signal amplified using a Tyramide
Signal Amplification Kit (Perkin-Elmer Ltd, UK) according to the manufacturer’s instructions.
E1^E4 protein and nuclei were identified with anti-16E1^E4 antibody TVG 405 conjugated to
Alexa 488 and DAPI (4’, 6-diamidino-2-phenylindole).
Immunofluorescence and immunohistochemistry
Immunofluorescence and immunohistochemistry were performed as described previously
[10]. For activated MAPK detection, the formalin fixed, paraffin embedded tissue sections
were incubated in solution D pH 9.0 (Dako, Glostrup, Denmark) for 10 min at room tempera-
ture prior to autoclaving for 2 min at 121˚C. The antibodies used were anti-phospho-ERK1/2
(Thr202/Tyr204) rabbit mAb (Cell Signaling Technology), anti-phospho-p38MAPK (Thr180/
Tyr182) rabbit mAb (Cell Signaling Technology), anti-phospho JNK rabbit polyclonal anti-
body (abcam, UK), anti-MCM2 rabbit polyclonal antibody (ab31159, abcam, UK), anti-HA
(16B12; Covance, Princeton, NJ) and anti-16E1^E4 antibody TVG 405 [34] conjugated to
Alexa 488 and an anti-E2 rabbit polyclonal antisera ([35]; a gift from Dr Yuezhen Xue, Insti-
tute of Medical Biology, Singapore). To measure the intensity and distribution of the stained
protein by ‘cross-sectional imaging’, digital images of immuno-fluorescently stained raft
Table 1. Primer and Probe.
Location Primer/Probe Sequence
HPV16 E4 Forward Primer GACTATCCAGCGACCAAGATCAG
Reverse
Primer
CTGAGTCTCTGTGCAACAACTTAGTG
TaqMan
Probe
CAGACACCGGAAACCCCTGCCAC
HPV18 E4 Forward Primer CCAGACGTCGGCTGCTACA
Reverse
Primer
GACAGGTCCACAATGCTGCTT
TaqMan
Probe
CCTGGACACTGTGGACTCGCGGA
GAPDH Forward Primer CCTCCCGCTTCGCTCTCT
Reverse
Primer
CTGGCGACGCAAAAGAAGA
TaqMan
Probe
TCCTCCTGTTCGACAGTCAGCCGC
https://doi.org/10.1371/journal.ppat.1006282.t001
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tissues were captured with a DeltaVision microscope and imaging system (GE Healthcare Life
Sciences) fitted with a 10x objective or using a Panoramic Slide Scanner, 3D Histotech, UK.
The captured images were then analysed using ImageJ in order to establish the intensity of
staining through the epithelial layers, from the basal layer to the cornified layer. For each
immunofluorescent stain, these ‘top to bottom’ scans were collected across 10 areas of equal
thickness that were derived from at least 3 different raft sections. Each of the graphs shown
(e.g. in Fig 1D and 1E) represents an average of at least 100 individual cross-sectional profiles
therefore, and is in general more representative of the raft phenotype than the individual IF
image. Where the tissue architecture of the raft was disrupted during the tissue sectioning (e.g.
image shown in Fig 1C (NIKS/HPV18 WT day 14), gaps in the continuity of the scan were
compensated for during the analysis. In most cases, such disruption was minimised by posi-
tioning blocks in the microtome so that the sectioning blade traversed the block from the epi-
thelial surface towards the epithelial basal layer. Because E4 can disrupt cell-cell contacts, such
disruption to raft structure was more obvious with the WT rafts and also at late time points.
Western blotting analysis
Proteins were extracted from tissue sections as previously described [36] and quantified using
the BCA protein assay kit (Pierce, UK), before being separated on 4–12% gradient polyacryl-
amide-SDS-Tris-Tricine denaturing gel (Invitrogen, UK) and transferred onto PVDF mem-
branes (Bio-Rad). After transfer, membranes were blocked for 1 hour at room temperature
in 1% milk in PBS-T (PBS, 0.1% tween20). Blots were then incubated overnight at 4˚C with
the appropriate primary antibody diluted in 1% milk PBS-T. Primary antibodies used were
anti-E2 rabbit polyclonal antisera [35], anti-tubulin clone B512 (Sigma, UK), anti-HPV16L1
(CAMVIR-1, Santa Cruz, USA), anti-GFP clone B-2 (Santa, Cruz), anti-16E1^E4 antibody
TVG 405 or anti-GAPDH clone 374 (Chemicon, UK), followed by the appropriate HRP-con-
jugated secondary antibody (GE Healthcare, UK), and detection using ECL, or ECL plus kits
(GE Healthcare, UK) or by the appropriate IRDye 800CW fluorescent secondary antibody
(Licor, UK) followed by detection using an Odissey imaging system (Licor, UK).
Vector construction and retroviral infection
The production and infection of recombinant lentiviruses and retroviruses were accomplished
as previously described [37]. Lentivirus or retrovirus vectors CSII-TRE-Tight-HA16E1, in
which the N-terminal hemagglutinin (HA)-tagged codon-optimized HPV16 E1 was inserted
under a tetracycline-responsive promoter, and pQCXIZeo-tetON ADV was described previ-
ously (the virus vectors were a gift from Tohru Kiyono, National Cancer Center Research
Institute, Tokyo, Japan [38, 39]). To introduce mutations into the HPV16E1 MAPK phosphor-
ylation sites, PCR-based mutagenesis was used with the KOD-plus mutagenesis kit (Toyobo,
Japan), with all mutants being completely sequenced to ensure that no additional changes had
been introduced. To generate SiHa cells expressing HA-HPV16E1 in a doxycycline-inducible
manner, SiHa cells were seeded 1 day before and inoculated with pQCXIZeo-tetON ADV at
MOI of 3 followed by zeocin selection (2 μg/ml). The generated SiHa-tetON cells were then
infected with CSII-TRE-Tight-HA16E1 (SiHa-tetON/CSII-TRE-tight-HA16E1). The expres-
sion of E1 was induced in the presence of 1 μg/ml of Doxycycline.
Recombinant adenovirus (rAd) infection and plasmid transfection
Recombinant adenoviruses (rAd) expressing 16E1^E4 (rAd16E1^E4) or β-galactosidase
(rAdβ-Gal) have been described previously [15, 40]. For infection experiments, 1x106 SiHa
cells were seeded into 90mm tissue culture dishes, or 1x104 SiHa-tetON/CSII-TRE-tight-
Differential life-cycle roles for HPV16 and 18 E4
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Fig 1. Loss of full length E1^E4 does not affect NIKS cell growth or the early stages of either the HPV16 or HPV18 life cycle.
(A) Cell growth in monolayer culture was monitored over a 10 day period after plating NIKS cells harbouring the WT or E4KO
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HA16E1 cells were seeded into Falcon 4 well culture slides (BD Biosciences, USA). 24h after
seeding, either rAd16E1^E4 or rAdβ-Gal was added to the media at a multiplicity of infection
(MOI) of 100. Cells were subsequently harvested at 24 or 48 h post-infection unless otherwise
stated. Transfection was performed using the Effectene Transfection Kit (Qiagen, UK) accord-
ing to the manufacturer’s protocol. The HPV16 E5-expressing SiHa cell line was established as
described previously [18].
Transient replication assays
Cells were seeded at a density of 4x105 cell per 60mm dish, and were transfected with pIRE-
S-E1E2 or pIRES-E1E2E4, and an HPV16 origin-containing plasmid (p16Ori), a kind gift
from Peter Howley (University of Harvard, USA) [41], using the Effectene transfection reagent
(Qiagen) according to the manufacturer’s instructions. The cells were harvested as for Western
blotting (above), and low molecular weight DNA was extracted as previously described [42]
and purified using Wizard spin columns (Promega). To distinguish replicated DNA from
input DNA, the extracted plasmid samples were compared before and after DpnI digestion by
Southern blotting as described by Del Vecchio et al [41]. To linearize p16Ori, the sample DNA
was digested with XmnI. The digested samples were separated by 1% agarose gel electrophore-
sis and then analysed by Southern blotting essentially as described previously [41]. To measure
the relative replication activity, the amount of amplified DNA was normalized to the signal of
the input p16Ori DNA for each experiment. Hybridisation signals were quantitated using a
Phosphor Imager (Storm) and Image Quant 5.0 software.
For the Luciferase DNA replication assays, NIKS cells were seeded at a density of 2x105
cells per well into 6-well plates without feeder cells, before being transfected using FuGENE
HD (Fisher Scientific, UK) with 2ug of pIRES-E1/E2 or pIRES-E1/E2/E4, along with 15ng
of the HPV16 origin-containing reporter plasmid (p16Ori-CMV-Gluc) and 15ng of pCMV-
Cluc2. 12 hours post-transfection, the media was replaced with F medium with all supplements
and feeder cells were added. 48 hours post-transfection, the media was replaced. 24 hours
later, culture media was collected and luciferase activity measured using a BioLux Gaussia
Luciferase Assay Kit and a BioLux Cypridina Luciferase Assay Kit (NEB, UK). Gaussia Lucifer-
ase activity was normalized against Cypridina Luciferase activity.
Southern blot analysis
Total genomic DNAs were isolated using QIAamp DNA blood mini kit. Total genomic DNAs
isolated from each population were digested with either BamHI or HindIII for at least 8h at
37˚C and electrophoresed on a 0.8% agarose gel. Total genomic DNA isolated from untrans-
fected NIKS cells was used as a negative control. Following electrophoresis, DNAs were trans-
ferred to a nylon membrane (Hybond-N; Amersham, Piscatway, NJ) and hybridized to [α-
32P]dCTP-radiolabeled DNA probe for full-length HPV16 prepared with Ready-to-Go DNA
genomes at the same cell density. Although both HPV16 and 18 increase the growth rate of NIKS, no difference was apparent when
WT and KO genomes were compared. The data are plotted as log10 cell number per well (averaged from triplicate experiments)
against time (days). (B) Raft tissue derived from NIKS cells harboring HPV16 WT and E4KO genomes was harvested at 8, 10, 12
and 14 day time-points post-differentiation prior to staining for E1^E4 (green), MCM (red) and DNA (blue; DAPI). MCM was used as a
surrogate maker for the expression of viral E7 protein. The dotted lines indicate the position of the basal layer. Images were captured
using a 10x objective. (C) Raft tissue derived from NIKS cells harboring HPV18 WT and E4KO genomes stained as in (A). (D & E)
The extent to which cells were driven into cycle in NIKS cells harbouring WT or E4KO was determined by measuring the extent and
intensity of MCM staining from the basal layer to rafts surface (see materials and methods) for the HPV16 (C) and 18 (D) WT or
E4KO raft tissues at day 14 post-differentiation. The distribution and intensity of E1^E4 in the WT rafts is shown as the grey shadow.
No consistent differences were apparent during the early stages of the virus life cycle.
https://doi.org/10.1371/journal.ppat.1006282.g001
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labelling system (GE Healthcare Life science). Radioactive bands were detected using a Storm
imaging system (Amersham).
Northern blot analysis and amplification of papillomavirus oncogene
transcripts (APOT) assay
Total RNAs from cells (C33a, SiHa) transfected with pIRES-16E1/E2/E4, pIRES-16E1/E2 or
pIRES (empty plasmid) were extracted using RNAeasy mini Kit (Qiagen). RNA samples were
electrophoresed on a 1.2% formaldehyde agarose gel. Following electrophoresis, RNAs were
transferred to a nylon membrane (Hybond-N; Amersham, Piscatway, NJ) and hybridized to
[α-32P]dCTP-radiolabeled DNA probe for E1E2E4 DNA fragment of HPV16 prepared with
Ready-to-Go DNA labelling system (GE Healthcare Life science). Radioactive bands were
detected using a Storm imaging system (Amersham). APOT assay using RNA sample of
NIKS/HPV16 was carried out following the protocol described previously [43].
Detection and quantification of viral gene expression by qPCR
Total RNAs from NIKS containing HPV genome cell were extracted using RNAeasy mini Kit
(Qiagen). Total RNA (1 μg) was reverse transcribed with 100 U of SuperScript III Reverse
Transcriptase (ThermoFisher scientific) using 100 μM random hexamer primers according to
the manufacturer’s instructions. Reactions were prepared in a volume of 20μl containing either
1×T ABsolute qPCR SYBR Green Mixes (ThermoFisher scientific) with 70nM of each primer.
Each primer set were designed to detect the viral gene transcripts specifically (the primer
sequences are available upon request). PCR was performed using a ViiA 7 system (Thermo-
Fisher scientific) with 15 min denaturation at 95˚C followed by 40 cycles of 95˚C for 15s, and
60˚C for 60s. For each real-time PCR assay, a standard curve experiment was performed to
allow absolute quantification of cDNA.
Results
Loss of full length E4 does not affect the early stages of either the HPV16
or HPV18 viral life cycle
The role of E1^E4 in the virus life cycle has been examined in different HPV types by different
groups using different cell backgrounds and protocols [13, 20–22], prompting us to carry out a
comparative analysis in the same cell background. To do this, a ‘generic’ keratinocyte cell line
that supports the life cycle of a range of different HR HPV types was used [23, 24], in conjunc-
tion with a common protocol for the transfection and maintenance of genome-containing
cells. As reported previously, this approach allows the generation of cell lines harboring HPV
genomes as viral episomes, with no obvious signs of viral genome integration, either by South-
ern blotting or APOT analysis (see [23] and S1 Fig). Blotting was carried out after blastocidin
selection and the expansion of HPV-containing cell populations, or after the isolation and
expansion of HPV-containing cell clones. In all cases, supercoiled, relaxed (open) circular, and
linear HPV genomes were detected, with a prominent 8Kb band being apparent after restric-
tion enzyme digestion using a single-cut restriction enzyme. Results from the analysis of three
clonal populations (T1, T2 and T3) are shown in S1A Fig as an example. The E6/E7 mRNA
expression pattern visualized in these cell lines by APOT assay indicates that these genes are
expressed from episomal rather than integrated viral genomes and is shown in S1B Fig, (tracks
T1, T2 and T3). The aberrant pattern seen in a cell line harboring integrated HPV genomes is
shown in the lane marked ‘IN’, with the range of episomal copy numbers seen in individual
clones being shown for HPV16 and 18 in S1C and S1D Fig. Although individual clones,
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(which represent expansion from single cells in the cell population) contained a range of geno-
mic copy numbers, viral episomes were always apparent. When making comparisons, we were
careful to adjust our transfection to achieve the same average copy number in the cell popula-
tion, or to use copy-number matched clones. The HPV16 E4KO mutant used in this study
contained a substitution of T3384 to A, in order to introduce a stop codon at amino acid posi-
tion 15 in the HPV16 E4 protein sequence. In the context of the HPV16 genome, this is the
shortest E4 truncation that is silent in the E2 reading frame. Although close to the E1^E4 slice
acceptor site at nucleotide 3357, the T3384 to A base substitution did not affect the relative
abundance of viral transcripts spanning E2 or E1, or the use of the E1^E4 splice site (S2A and
S2B Fig). Cell lines harbouring this mutant genome as a viral episome were successfully estab-
lished, as described previously by Nakahara and colleagues [13]. In HPV18, the E4KO mutant
was made by double point mutations of T3467 to A and T3470 to A, which introduces two stop
codons at position 17 and 18 of the E4 coding sequence without changing the coding capacity
of the E2 ORF. Comparable with the results from the HPV16 analysis, no changes in patterns
of transcription were seen. NIKS populations and clonal cell lines containing the wild type
(WT) and E4KO genomes of both HPV types were subsequently prepared. Interestingly, the
average genome copy in transfected NIKS population was often higher for HPV18 (approxi-
mately 200 copies/cell) than HPV16 (approximately 100 copies/cell), and while individual
clones derived from each transfected NIKS population exhibited a range of episomal copy
numbers (see S1C and S1D Fig), no significant differences were seen between NIKS cells har-
bouring WT or E4KO genomes, allowing isogenic WT or E4KO cell line pairs with similar
copy numbers to be selected for comparative analysis. To generate cell populations with
matched copy number, we found that a lower level of HPV18 genomic DNA was generally
required at the transfection stage.
Previous studies have suggested that loss of full length HPV18 E1^E4 can confer a growth
advantage on undifferentiated primary human foreskin keratinocytes [21]. To look at this fur-
ther, HPV16 or 18, copy-number matched WT or E4KO-containing NIKS were plated, and
grown in monolayer culture, from day 1 to day 10 (Fig 1A). NIKS were harvested after removal
of feeder cells, and counted using a Z1 Coulter Particle Counter (Beckman Coulter, California,
United States). Monolayer tissue culture approximates the epithelial basal layer, especially at
confluence when cells become contact inhibited but have not begun to differentiate [23]. Such
cells lack detectable E4 by immunostaining. As shown in Fig 1, the WT and E4KO genomes of
both HPV16 and 18 confer a growth advantage on NIKS keratinocytes when compared to
parental cells. However, no significant and/or reproducible difference was apparent between
WT and E4KO genomes of either HPV16 or 18. When taken together, these results indicate
that the E1^E4 protein does not obviously contribute to early events in the HPV life cycle,
such as the initial amplification following infection, the maintenance replication of the viral
genome or the regulation of the viral proteins that drive cell proliferation in the basal layer.
We next considered whether this lack of an obvious E4 function in basal cells extended to
the basal and parabasal layers when cells were propagated in organotypic raft culture. Raft cul-
ture provides a spatial separation of cells at various stages of differentiation, and closely mimics
the differentiation and organization of normal epithelial tissues. Rafts were harvested at 8, 10,
12 and 14 days after placing the cell monolayer at the air/liquid interface in order to examine
the consequences of E4 loss as the extent of differentiation increases. As expected, E4 was not
detectable in the lower epithelial layers by immunofluorescence staining at any of the time
points, but was apparent in the upper epithelial layers in the WT rafts (Fig 1B and 1C, right
panels), becoming more extensive as the extent of differentiation increased from day 8 to 14.
The extent of cell cycle entry in basal and parabasal layers was examined by staining for the
cellular MCM protein. MCM can be regarded as a surrogate marker of E7 expression when
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present above the basal layer in HPV-driven rafts [23], with expression declining as the extent
of differentiation increased from day 8 to 14. Because of this, raft tissues of similar thickness,
and which exhibited a similar degree of differentiation were chosen for comparison. As shown
in Fig 1B and 1C, no obvious differences in MCM staining were apparent between WT and
E4KO rafts at any of the time points examined, with broadly similar results for HPV16 and 18.
To rule out the possibility that E4 may affect either the density of MCM-positive cells in the
lower epithelial layers, or the intensity of staining in each cell, HPV 18 WT and E4KO rafts
were digitally scanned from basal layer to the top and analyzed by cross-sectional imaging
analysis (Fig 1D and 1E). Again, no obvious difference was apparent in the MCM expression
profile in the lower epithelial layers, supporting the conclusion that the early stages of the virus
life cycle are not dependent on HPVs ability to express E4. A similar observation was previ-
ously reported using an in vivo model of E4 function and neoplastic progression in the CRPV/
domestic rabbit system [44].
HPV16 and 18 genome amplification is delayed rather than abolished in
the absence of E4 following differentiation
During the HPV life cycle, viral genome amplification begins during host epithelial differen-
tiation, and is coincident with E1^E4 expression [6, 31]. Indeed, the role of E1^E4 in viral
genome amplification has been examined using a number of HPV genomic mutants in differ-
ent cell backgrounds using a range of differentiation protocols [13, 20–22]. Despite differences
in the extent of productive infection in these systems, an almost complete failure to support
genome amplification was reported for HPV18 and 31 [20, 21], with no effect on genome
amplification reported for HPV11 [22]. Here we have focused specifically on the two most
important high-risk HPV types (HPV16 and 18) using a common isogenic cell background,
with differentiation being carried out over an 8–14 day time course. We conclude from this
more extensive analysis, that E4 is not in fact essential for viral genome amplification, as in situ
hybridization signals were apparent in the middle and upper layers of both WT and E4KO
mutants in both the HPV16 and 18 rafts (Fig 2A and 2C). While viral genome amplification
can thus be triggered without E4 proteins, its detection by in situ hybridization was however
much reduced in HPV16 E4KO raft tissues at all time-points (Fig 2A), and was much more
apparent when the extent of differentiation in the raft was limited (i.e. day 8 and 10). The loss
of E4 had no apparent effect on differentiation however, as revealed by hemotoxylin and eosin
staining (H&E), and the detection of early and late differentiation markers (keratin 10 and
filaggrin) (S3 Fig). In fact the raft time course experiments described here may explain the het-
erogeneity of results reported previously, with E4 effects becoming less apparent as the extent
of epithelial differentiation increases over time. To examine this more precisely, the 10 and 14
day raft time-points were digitally scanned (Panoramic Slide Scanner, 3D Histotech, UK), and
the number and intensity of the HPV in situ-positive cells averaged across 10 raft sections of
comparable thickness. Using this approach, which overcomes some of the limitations of show-
ing just selected images, the extent of genome amplification was found to be around three fold
higher in the NIKS/HPV16 rafts when compared to the NIKS/HPV16 E4KO rafts at both the
10 and 14 day time points. Comparable raft cultures prepared with the HPV18 E4KO NIKS
showed a much less dramatic reduction (Fig 2C). At day 10 and 12, viral genome amplification
was lower with the E4KO mutant than with the WT genome, but by day 14, viral genome
amplification was similarly extensive in both the WT and E4KO genomes (Fig 2D). Although
such in situ methodologies are particularly useful in understanding events in heterogeneous
tissues such as rafts (Fig 2B and 2D), we went on to also examined raft sections by qPCR and
western blotting following laser capture microscopy (LCM) and/or epithelial microdissection
Differential life-cycle roles for HPV16 and 18 E4
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006282 March 17, 2017 12 / 38
Fig 2. Differentiation dependent HPV genome amplification is delayed rather than abolished in the absence of E1^E4. (A) Viral genome
amplification after differentiation was detected by in situ hybridization (red) in raft tissues generated from NIKS cells harboring HPV16 WT or E4KO
genomes. Time post-differentiation is indicated in days on the left. Staining for E1^E4 and DNA (DAPI) are shown as green and blue. The dotted line
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(Fig 2E and 2F). Similar to what was seen in the in situ hybridisation studies (Fig 2A–2D), the
effect of E4KO on genome amplification (Fig 2E (and L1 accumulation (Fig 2F)) was again
seen much more clearly with HPV16 than HPV18. When taken together, these results indicate
that for both HPV16 and 18, genome amplification is restricted rather than abolished in the
E4KO cells upon differentiation, with apparently similar levels of genome amplification being
seen irrespective of E4 presence in the mature HPV18 rafts.
Capsid protein expression appears linked to genome amplification
success, and is not necessarily compromised by E4 loss
The final stages of the HPV productive cycle involve expression of the viral capsid proteins (L1
and L2), to allow genome packaging. To address whether the absence of E1^E4 directly com-
promises the expression of capsid proteins per se, we compared the extent to which L1 accu-
mulation is dependent on E4 in HPV16 and HPV18 rafts during our time course. Indeed, this
was initially suggested from the analysis of total protein extracts prepared from SDS-solubi-
lised, microdissected day 14 raft epithelium shown in Fig 2F, where the HPV16 E4KO was
found to support L1 accumulation only poorly. When L1 distribution was examined, the
extent of L1 expression was found to be lower than WT in the HPV18 E4KO rafts at day 10
and 12, equivalent by day 14, when differentiation was more extensive (Fig 3A). This pattern is
very similar to that seen for viral genome amplification, suggesting that genome amplification
and capsid synthesis are coordinated events. The similarities seen between the day 14 rafts sug-
gest that 18 E1^E4 does not play an essential role in either the regulation of genome amplifica-
tion or the expression of virion structural proteins (Fig 2C, Fig 3A). By contrast, no detectable
L1 was found in raft tissues containing HPV16 E4KO mutants by immunofluorescence (Fig
3B), only barely detectable levels of L1 transcripts and L1 protein detectable by Western blot-
ting (Fig 2G). During the course of our experiments, three different HPV16 E4KO populations
were examined, as well as one clonal cell line harboring the HPV16 E4KO genome, but on no
occasion did we detect any expression of 16L1 by immunofluorescence staining. In our experi-
ence, HPV16 NIKS are always less proficient in supporting the full productive life cycle than
HPV18 NIKS, with the absence of 16L1 expression possibly reflecting the lower base levels of
genome amplification seen with HPV16 (Fig 2A). No obvious differences were noticed how-
ever when patterns of differentiation-dependent transcription were compared [13]. We sus-
pect in fact that the different contributions of E4 to the life cycle of HPV16 and HPV18 may
reflect differences in the ability of each HPV type to complete their life cycle in the common
‘generic’ keratinocyte background used here, and maybe also to differences in the in vivo dis-
ease-associations of these two HPV types.
G2 arrest function of HPV16 E4 contributes to viral genome amplification
and L1 expression
Since loss of E4 affected HPV16 genome amplification and L1 expression more dramatically
than HPV18, we focused our subsequent analysis on HPV16, and in particular, the role of E4
in this process. A well-established function of 16E4 when expressed at high-level, is its ability
indicate the position of the basal layer. Images were captured using a 10x objective. (B) The average number of cells showing evidence of HPV16
viral genome amplification as revealed by in situ hybridization were counted from 10 raft sections of comparable thickness in the NIKS HPV16 rafts.
(C) Viral genome amplification after differentiation was detected as described in (A) above, although in this case, rafts were derived from NIKS
harboring HPV18 WT or KO genomes. (D) The average number of cells showing evidence of HPV18 viral genome amplification were counted as
outlined in (B) above. (E) Total DNA was extracted from microdissected raft epithelium (WT or E4KO) at the 14 day time point, and total HPV16 (left)
and HPV18 (right) genomic DNA was quantified by qPCR. (F) Total protein was extracted from microdissected raft epithelium (WT or E4KO) at the 14
day time point, and the levels of E4 and L1 protein visualised by western blotting.
https://doi.org/10.1371/journal.ppat.1006282.g002
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Fig 3. Viral capsid protein expression appears linked to viral genome amplification success in HPV16 and 18 rafts. Raft sections derived
from NIKS cells harboring HPV18 (A) or HPV16 (B) WT or E4KO genomes were analyzed at different time points post-infection, before being
stained for E1^E4 (green), L1 (red) and DNA (blue; DAPI). The dotted lines indicate the position of the basal layer. Images were captured using a
10x objective.
https://doi.org/10.1371/journal.ppat.1006282.g003
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to cause cell cycle arrest in a G2-like phase, where viral DNA replication may proceed in the
absence of cellular replication [14, 15, 45]. It has been hypothesised that this may facilitate the
timely onset of viral genome amplification during epithelial differentiation by antagonizing
the proliferative functions of E6 and E7 [45]. Given the clear effect of E4 loss on HPV16 ge-
nome amplification, we were prompted to further explore this hypothesis. Our previous stud-
ies have shown that HPV16 E1^E4-mediated G2 arrest depends on a PTTP motif at amino
acid position 21–24. A mutant 16E1^E4 in which these two threonines were mutated to ala-
nines (i.e. T22A, T23A (PTTP motif changed to PAAP)) no longer inhibited mitotic entry
[15]. Since the E4 ORF lies entirely within the E2 gene, the preparation of a G2 arrest-mutant
in the context of the full length HPV16 genome could only be made by mutating the E4 PTTP
motif to PIIP (E1^E4 T22I, T23I), a modification that introduces only silent changes into the
E2 coding sequence. To confirm that the 16E4 PIIP mutation (i.e. T22I, T23I in 16E1^E4)
abolishes the G2-arrest function of E4, WT E4 and the 16E1^E4 PIIP mutant were first ex-
pressed in Cos-7 cells as described previously [15]. 24 hours after transfection, cells were
treated with nocodazole to disrupt mitotic spindle formation, before being left for an addi-
tional 24 hours to allow cell-cycle progression. Any cells passing from G2 into M, that are not
arrested by E4, will subsequently be arrested in mitosis as a result of the nocodazole treatment.
These cells were subsequently visualized by double staining using an anti-16E1^E4 antibody
conjugated to Alexa-fluor 488 in conjunction with an antibody to the mitotic marker, phos-
pho-histone H3 and visualization by microscopy. As shown in Fig 4A, the 16E1^E4 PIIP
(T22I, T23I) mutant protein no longer inhibited cell cycle progression in G2, with the number
of cells passing from G2 to M being broadly similar to what is seen with the GFP control. WT
E4 by contrast, reduced the number of cells progressing from G2 to M, which has been shown
previously to result from its G2-arrest function. We next prepared the E4 PIIP mutant in the
context of the HPV16 genome, before introducing both the WT and mutant genomes into
NIKS cells. Both WT and the E4 PIIP mutant genomes were maintained at similar copy num-
ber prior to differentiation. To establish how loss of E4’s G2-arrest function affected HPV16
genome amplification, we used the organotypic raft culture system described above, in parallel
with a methylcellulose-based differentiation system. Although differentiation in methylcellu-
lose does not perfectly mimic epithelial differentiation in vivo, the approach does facilitate
quantitation of viral genome copy number. In our experiments, NIKS cells harbouring either
the WT or the E4 PIIP genomic mutant were suspended in 1.5% methylcellulose [46], and har-
vested at 0h, 24h, 48h and 72h. Viral DNA copy number was measured by qPCR, and normal-
ized to cell number using primers directed to the cellular GAPDH gene (see materials and
methods). The qPCR results showed that HPV16 DNA copy numbers per cell were slightly
reduced in the E4 PIIP genomic mutant, as compared to the WT HPV16 genome at all time-
points (Fig 4B), with the trend suggesting statistical significance (P<0.05). To examine the role
of the G2 arrest motif more thoroughly, the NIKS cell populations harbouring either the WT
or E4 PIIP HPV16 genomes were grown in organotypic raft culture. By in situ hybridization
and immunofluorescence, less genome amplification and L1 expression were apparent with
the 16E4 PIIP mutant genome tissues (Fig 4C and 4D). The finding that L1 levels were reduced
but not absent contrasts sharply with the complete loss of capsid protein expression seen with
the 16E4 KO genome (see Figs 3B and 4D). As seen for HPV16 E4KO, the E4PIIP mutant
genome did not show any obvious differences in the relative abundance of transcripts span-
ning the early region (S2 Fig), with the reduction in late transcripts being expected because of
the lower levels of genome amplification. When taken together, the organotypic raft results
appear in broad agreement with the data obtained from the methylcellulose experiments, and
indicate that the G2 arrest function of 16E4 contributes importantly to successful life cycle
completion. Interestingly, previous work with HPV18 has suggested that the 18E4 G2 arrest
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function does not contribute in a similar way to the life cycle of HPV18 [47]. We suspect that
this may be linked to differences in patterns of E6/E7 expression between the HPV16 and
HPV18 rafts, with HPV18 producing a robust and well-ordered productive life cycle in orga-
notypic raft systems. Our previous work has shown that HPV16 produces a range of pheno-
types using this model, including those that resemble the CIN 1 and 2 seen in patients [23]. In
this setting, it is perhaps not surprising that the anti-proliferative effects of E4 may contribute
positively to genome amplification success.
Fig 4. The G2 arrest function of HPV16 E1^E4 contributes to viral genome amplification and L1 expression. (A) Mitotic index of Cos-7 cells
expressing either the HPV16 WT E1^E4 protein, the E1^E4 PIIP mutant that is defective in G2 arrest function, or a control protein (GFP) that does not
inhibit cell cycle progression. The E1^E4 PIIP mutant has lost its ability to prevent mitotic entry when compared to WT 16 E1^E4. (B) HPV16 WT or PIIP
mutant genome-containing NIKS were suspended in 1.5% methylcellulose (MC) in order to induce differentiation, and were harvested at 0h, 24h, 48h
and 72h. Genomic DNA copy numbers were measured by qPCR. The results are presented as fold-increase in HPV16 genome copy number relative to the
zero hour time point. A reduction in genome amplification success was noticeable at all time points. (C & D) Viral genome amplification and L1 expression
were examined at day 14 post-differentiation by fluorescence in situ hybridization (FISH signal shown in red in C) and indirect immunofluorescence (L1
staining shown in red in D) in raft tissues derived from NIKS cells harboring either the HPV16 WT or E4KO genomes. Viral genome amplification and L1
expression were compromised in the PIIP mutant. The dotted lines indicate the position of the basal layer. Images were captured using a 10x objective.
https://doi.org/10.1371/journal.ppat.1006282.g004
Differential life-cycle roles for HPV16 and 18 E4
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006282 March 17, 2017 17 / 38
Different contributions of 16 and 18 E4 to p38 and pERK1/2 MAPK
activation during the HPV life cycle
MAPK (mitogen-activated protein kinase) is an important regulator of viral protein function
and viral genome amplification [48], which occurs in the upper layers of HPV-infected epithe-
lial tissue as cells are driven through S-phase and into G2. In addition, it has also been sug-
gested that 16E4 may stimulate p38 MAPK as part of a cellular stress response [49], prompting
us to examine whether this additional E4 function may also play a role in HPV genome ampli-
fication. To examine this, we first examined HPV16 WT and E4KO day 14 rafts by immunos-
taining and ImageJ analysis (Fig 5A and 5B). Although p-p38MAPK could be detected in the
basal and parabasal layers in both WT and E4KO rafts, the WT rafts showed a marked elevated
p-p38 MAPK in the middle and upper layers where E4 accumulation was seen (Fig 5B). Previ-
ous studies using undifferentiated monolayer cell culture systems have shown that both E4
and E5 can activate p38 MAPK [49, 50], which is compatible with our observations (S4 Fig).
Interestingly, loss of 16E4’s keratin-binding motif (Δ16N), as occurs in the upper epithelial lay-
ers where p38 MAPK activation was observed (Fig 5A), did not significantly compromise E4s
ability to activate p38 MAPK in this system (S4 Fig), although as expected, N-terminal deletion
led to E4 accumulation because of its increased ability to assemble into amyloid-like fibrils [19,
51]. In addition to p38 MAPK [49], HPV16 E4 can stimulate other members of the MAPK
family in monolayer cell culture [18], with ERK1/2 activity triggering the initial association of
16E4 with the cellular cytokeratin network [10]. Interestingly, p-ERK1/2 had a similar distri-
bution in both the WT and KO HPV16 rafts, and was confined to the mid epithelial layers
close to the point where E4 levels start to accumulate (Fig 5C and 5D). A difference in the
intensity of p-ERK1/2 staining was however apparent, with a generally lower signal in the
HPV16 E4KO rafts (Fig 5D), with the profiles revealing a different distribution of p-ERK1/2
and p-p38 MAPK in the mid and upper epithelial layers (Fig 5B and 5D). For HPV18, this
prominent difference was less apparent when p-p38 levels were compared (S5A and S5B Fig).
No apparent difference was seen in either the abundance or the distribution of p-ERK1/2
between HPV18 WT and E4KO rafts (S5C and S5D Fig).
16E4 but not 18E4 maintains active cytoplasmic p-JNK MAPK during the
HPV16 life cycle
Several studies have implicated elevated MAPK activity and transition into the G2 phase of the
cell cycle as being important for HPV genome amplification, and it is notable from the above,
that the activity of one member of the MAPK family (i.e. p-ERK1/2), rises transiently in both
the HPV16 and 18 rafts in the mid epithelial layers where genome amplification occurs. The
HPV E1 protein, which is a DNA helicase/ATPase required for viral genome amplification, is
a target for both p-ERK1/2 and p-JNK MAPK as well as CDK1 (a kinase activated in G2), with
phosphorylation of E1 affecting its nuclear/cytoplasmic localization [48]. The reduced viral
genome amplification seen in 16E4 KO mutants, and the apparent dependency on E4 for
HPV16-mediated MAPK elevation, prompted us to extend our analysis of E4s effects to
include p-JNK. To our surprise, p-JNK showed by far the most dramatic change in the pres-
ence of 16E4, with p-JNK and E4 co-localizing precisely in the cytoplasm of cells in the mid
epithelial layers and above (Fig 6A). Cytoplasmic p-JNK was however seen sporadically prior
to the onset of E4 expression in the middle layers of the epithelium, but was only ever sustained
from the mid to upper epithelial layers when 16E4 was expressed (compare HPV16 E4KO and
WT panels in Fig 6A). This sporadic expression of cytoplasmic p-JNK in the basal and paraba-
sal layers prior to its accumulation in E4-positive cells was a direct consequence of HPV pres-
ence in the cell, and was never seen in the NIKS parental rafts where the p-JNK patterns were
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Fig 5. 16 E1^E4 contributes to p38 MAPK and ERK1/2 activity during the HPV16 life cycle. (A) Raft tissues from NIKS containing HPV16 WT or
E4KO genomes were harvested at day 14 post-differentiation and stained for 16E1^E4 (green), phospho-p38 MAPK (p-p38 MAPK) (red) and DNA
(blue; DAPI). An elevation of p-p38 MAPK staining in the upper layers of the raft is apparent in rafts generated using the WT HPV16 genome. The dotted
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almost exclusively nuclear (Fig 6A, bottom panels). Because the p-JNK/E4 co-localisation pat-
tern was so striking, we next went on to establish whether a similar pattern could be seen in
vivo in low-grade cervical neoplasia caused by HPV16. A noticeable similarity was apparent
when p-JNK and E4 staining in CIN1 was compared to the WT HPV16 rafts, and similarly
when uninfected cervix was compared to uninfected NIKS rafts (Fig 6B, left panel). In both
instances, 16E4 and p-JNK localize closely as E4 accumulation first begins in the mid epithelial
layers, with staining eventually declining as the cells reach the epithelial surface. Although the
Cytoplasmic p-JNK staining was more prominent, in both the 16 WT rafts and the HPV16
CIN1 lesion, p-JNK was also apparent in the nucleus of the E4-positive cells (see Fig 6A). Cyto-
plasmic activated JNK was never observed in normal uninfected cervix (Fig 6B, right panel),
which showed a distribution similar to that seen in the NIKS-only rafts. Interestingly, the dra-
matic E4/p-JNK co-localization seen with HPV16, was not seen in organotypic rafts generated
using HPV18 WT or E4KO genomes (Fig 6C), and in this context, it is notable that the other
MAPK members were also not notably affected by 18E4 (S5 Fig). Although examined exten-
sively in repeat experiments, the prominent effects seen with HPV16, did not extend to either
HPV45 or HPV31 (Fig 6D and 6E), although HPV18, 31 and 45 all showed some evidence of
nuclear p-JNK, which tended to decline as E4 levels increased (Fig 6C, 6D and 6E). These
results suggest that cytoplasmic pJNK-sequestration during the papillomavirus life cycle may
be a HPV16-specific function, rather than a general characteristic of high-risk HPV types. As
discussed above, the pJNK pattern seen in HPV16 NIKS rafts was broadly comparable to what
was seen in HPV16-associated CIN despite the mucosal epithelial origin of the latter (Fig 6A
and 6B).
HPV16 E4-mediated kinase activation and the modulation of HPV
replication proteins represents a novel mechanism by which 16E4
optimises viral genome amplification success
Although use of the organotypic raft culture system, when combined with the analysis of clini-
cally-derived biopsy material remains central to our understanding of HPV biology, the use of
undifferentiated cells in cultured monolayer can be used to provide valuable additional mecha-
nistic information. To examine the different abilities of the HPV16 and 18 E4 proteins to mod-
ulate p-JNK activity and to consider the consequence of this, the E1^E4 proteins of these
viruses were first examined in isolation using undifferentiated epithelial cells grown in mono-
layer culture. As seen in the organotypic raft system, the HPV16 E1^E4 protein (Fig 7A, 7B
and 7C), but not that of HPV18 (Fig 7D) lead to the cytoplasmic accumulation of p-JNK in
SiHa cells (Fig 7B and 7C), as well as producing this phenotype in monolayer NIKS cells (Fig
7A). To do this, cells were infected with the recombinant adenovirus expression vectors,
Ad.16E1^E4, Ad.18E1^E4 or Ad.βGal, as described previously [15] with E4, β–gal and p-JNK
being localized by indirect immunofluorescence as described in the Materials and Methods
[49]. These results suggest that 16 E1^E4, but not 18 E1^E4, can sequester active p-JNK in the
lines indicate the position of the basal layer. Images were captured using a 10x objective. (B) The extent and intensity of p-p38MAPK staining in the
HPV16 WT and E4KO raft tissues at the 14 day time-point post differentiation was digitally scanned from the basal layer to the top of the raft tissue as
described in the materials and methods. The expression of E4 in the WT raft is shown as the grey shadow. A very different level of p-p38 MAPK activity
was apparent in the upper epithelial layers of rafts prepared using the WT HPV16 genome. (C) Raft sections from HPV16 WT or E4KO harvested at 8,
10, 12 or 14 days respectively post-differentiation were stained for 16E1^E4 (green), p-ERK1/2 (red) and DNA (blue; DAPI), to reveal differences in the
levels of ERK1/2 activity in the mid epithelial layers. The dotted lines indicate the position of the basal layer. Images were captured using a 10x objective.
(D) The extent and intensity of p-ERK1/2 staining in NIKS rafts harboring HPV16 WT or E4KO raft tissues at day 14 was examined by digitally scanning
the raft tissue from the basal layer to the top of the raft as described in materials and methods. The distribution and intensity of E1^E4 staining in the WT
raft is shown as a grey shadow. Comparison with data shown in (B) reveals 16E1^E4’s effect on ERK1/2 to be largely confined to the mid epithelial
layers, which is distinct from the E4-mediated effect on p38 MAPK which is prominent in the upper epithelial layers.
https://doi.org/10.1371/journal.ppat.1006282.g005
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Fig 6. E1^E4 expression is required for the maintenance of activated pJNK in the cytoplasm during the late stages of the HPV16 life cycle.
(A) Raft tissues derived from NIKS cells or NIKS cells harboring HPV16 WT or E4KO genomes were analyzed at day 14 post-differentiation after
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cytoplasm in absence of other viral proteins, as seen in organotypic rafts. It has previously
been shown that 16 E1^E4 associates with the cellular cytokeratin network in both NIKS and
SiHa cells, and in SiHa cells promotes network collapse to the nuclear periphery [52]. The
characteristic perinuclear E4 distribution is apparent in the enlarged image shown in Fig 7C,
and although there is some variation in the p-JNK levels between cells, the co-localisation with
16E4 is reproducibly seen, with some cells showing the characteristic E4/keratin perinuclear
bundles (arrowed) (Fig 7C, and [49, 53]).
The various effects seen with 16E1^E4 on members of the MAPK family, coupled with the
ability of 16E1^E4 to arrest cells in G2, suggests that 16E4 may be contributing to genome
amplification-success by modulating the intracellular environment to favour the phosphoryla-
tion of viral and cellular proteins by these kinases. Although such effects on the cell are likely
to be complex and to involve multiple targets, we decided to make a first investigation of this
by examining whether E4 expression had any effect on the location of the HPV16 E1 helicase,
which is required for genome amplification, and which has been reported to shuttle between
the nucleus and the cytoplasm depending on the extent of phosphorylation by members of
the MAPK and Cyclin-Dependent Kinase (CDK) families. Amino acid sequence alignment
revealed that these phosphorylation sites are conserved amongst the E1 proteins of HPV16,
HPV31 and HPV11, with the latter containing an additional upstream phosphorylation site
(see Fig 8A and [48, 54, 55]). Our initial E1/E1^E4 co-transfection experiments resulted in
only a small number of cells co-expressing the two proteins. To overcome this difficulty, we
established an inducible cell line in which a HA-tagged 16E1 protein is expressed from a doxy-
cycline inducible promoter using a lentivirus CSII-TRE-tight-HA16E1 construct. A SiHa
background was used for these experiments, as SiHa cells constitutively express the HPV16 E6
and E7 proteins, that would be expressed along with E1^E4 and E1 in cells supporting viral
genome amplification in vivo. We were unable to generate cell lines constitutively expressing
the E1 protein however, presumably because of E1-mediated cell toxicity following overexpres-
sion. Lentivirus infection was carried out into Tet-On SiHa cells prepared using retrovirus
pQCXIzeo-tetON ADV followed by selection in zeocin as described in the Materials and
Methods. In agreement with the hypothesis that E4 expression may modulate the function of
other viral gene products, a very clear increase in E1 nuclear localization was apparent when
expression was carried out along with E4 in the same cell (Fig 8B), with E4 expression leading
to a statistically significant change in intracellular E1 distribution (Fig 8D). Statistical analysis
was facilitated by combining the inducible E1 expression system with use of the rAd16E1^E4
expression vector, which ensured E1/E4 double-positivity in the majority of cells expressing
E1 in the dish. In contrast to the wt 16E1 protein, the phospholyation site-deficient E1 protein
(E1S93A.S107A) was found primarily in the cytoplasm, with the presence or absence of 16E4
having little effect on its intracellular location (Fig 8B and 8C). The % of cells showing nuclear
E1 in the presence or absence of E4 was calculated from the analysis of 3000 E1-positive cells is
shown in Fig 8D.
staining for 16E1^E4 (green), phospho-JNK (p-JNK, red) and DNA (blue; DAPI). Although elevated cytoplasmic JNK MAPK was apparent before
16E1^E4 became abundant, its activity was noticeably elevated and persisted in cells expressing 16E4. Cytoplasmic p-JNK was not apparent in rafts
prepared using ‘empty’ NIKS cells. The boxed areas are enlarged in the right panel. The dotted lines indicate the position of the basal layer. Images
were captured using a 10x objective. (B) Tissue sections from HPV16-induced cervical lesions or normal cervix were stained for 16E1^E4 (green), p-
JNK (red) and DNA (blue; DAPI). The pattern of p-JNK seen in HPV16-induced cervical lesions and in normal cervical tissue was broadly similar to that
seen in NIKS-HPV16 rafts and ‘empty’ NIKS rafts respectively. The boxed areas are enlarged in the lower panel. The dotted lines indicate the position of
the basal layer. Images were captured using a 10x objective. (C) Raft tissues derived from NIKS cells or NIKS cells harbouring the HPV18 WT or E4KO
genomes were analysed at day 14 post-differentiation. In contrast to the situation seen with HPV16 (see (A) above), no obvious E4-mediated
cytoplasmic p-JNK association was apparent. (D, E) p-JNK staining in rafts produced from NIKS cells containing either HPV45 (D) or HPV31 (E) show
an absence of E4-mediated p-JNK sequestration.
https://doi.org/10.1371/journal.ppat.1006282.g006
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Fig 7. 16E1^E4 expression sustains JNK activation and cytoplasmic sequestration. (A) NIKS cells were infected for 48 hours with rAd.16E1^E4
or rAd.β-Gal as a negative control. The cells were stained for 16E1^E4 (green) or β-Gal, p-JNK (red) and DNA (blue; DAPI). As seen in vivo, 16E1^E4
expression is associated with a dramatic elevation in cytoplasmic p-JNK staining. (B & C) SiHa cells were infected for 48 hours with rAd.16E1^E4 or
rAd.β-Gal (negative control), before being stained for 16E1^E4 or β-Gal (green), along with p-JNK (red) and DNA (blue; DAPI). In SiHa cells, the p-JNK
staining is associated with the perinuclear collapsed E1^E4 keratin networks which can be visualised more clearly in the enlarged image shown in (C).
Perinuclear E4/Keratin bundles are arrowed. (D) SiHa cells were infected for 48 hours with rAd.18E1^E4 as described above. Cytoplasmic p-JNK
staining (red) was not observed. Cells were co-stained for the 18E1^E4 protein (green) and DAPI (blue).
https://doi.org/10.1371/journal.ppat.1006282.g007
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Fig 8. 16E1^E4 expression drives nuclear accumulation of wild type but not mutant 16E1 and enhances E1/E2-mediated HPV16 ori-
dependent replication. (A) Sequence alignment showing the location of conserved MAPK phosphorylation sites involved in regulating E1 nuclear/
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Given that the presence of E4 can facilitate E1 nuclear accumulation, we next wanted to
establish whether E4 could also enhance E1/E2-mediated viral genome replication in a func-
tional assay. Because E1, E2 and E4 are not expressed at equivalent levels during genome
amplification, a HPV16 viral DNA fragment encoding just the E1/E2/E4 region was first iso-
lated from the HPV16 WT or E4KO genome, and cloned downstream of a CMV promoter
positioned immediately in front of E1 (S6A Fig). With respect to the E1, E2 and E4 open read-
ing frames, the position of the CMV promoter in these clones (pIRES-16E1/E2/E4 or pIRES-
16E1/E2) mimics that of the HPV16 late (p670) promoter in the viral genome, which drives
the co-ordinated expression of E1, E2 and E1^E4 during viral genome amplification. In agree-
ment with data shown in S2 Fig, the pIRES plasmids exhibited similar transcription profiles
across the E1, E2 and E1^E4 regions to those seen with the full-length viral genome (S6B Fig),
with E2 and E4 also being detectable by western blotting (S6C Fig). As expected, E4 was not
apparent in cells transfected with the E4KO plasmid, (pIRES-16E1/E2), and in the absence of a
HA tag, E1 protein could not be reliably visualized using available antibodies (S6C Fig). In fact
E1 transcript levels were tightly regulated in this system, just as they are during the HPV16 life
cycle [56–60]. Interestingly, and as reported previously, total E2 levels were always elevated in
the presence of E4, in agreement with previous studies showing that E2 can become seques-
tered and stabilized in the cytoplasm in undifferentiated cells expressing both proteins together
[61]. In addition to E1 nuclear localization therefore, it remains a possibility that E2 cellular
accumulation may also contribute to E4’s overall effects on genome amplification. The precise
mechanism by which E4 affects E2 abundance, and the possible effects of MAPK phosphoryla-
tion are not however known, although a direct interaction between E1^E4 and E2 in the cyto-
plasm has been previously reported [61]. As with most HPV early proteins [62], the detection
of E1 has never been shown in raft tissue, and the detection of HPV16 E2 during productive
infection has only been convincingly reported with a single purified rabbit polyclonal antise-
rum [35], with other antibodies to the HPV16 E2 protein failing to detect the protein during
productive infection using immunofluorescence or immunohistochemistry protocols. Unfor-
tunately, this purified antibody is no longer available from the researchers who originally pro-
duced it (Dr Yuezhen Xue, Institute of Medical Biology, Singapore, personal communication),
although we were able to obtain a small aliquot of the unpurified rabbit serum. Curiously, our
optimized staining protocol using this antibody did appear to show an elevated in E2 signal in
the middle layer of HPV16 WT rafts, when compared with E4KO rafts (S7A and S7B Fig),
with nuclear E2 staining apparent at around the time of E4 elevation (S7B Fig). Although back-
ground staining was higher than we would have liked using this antibody, the conclusion was
supported by digital scanning across the length of the raft tissue (S7C Fig). In contrast to the
situation in undifferentiated monolayer cells however, the detectable E2 protein seen in the
cytoplasmic shuttling in HPV11, 31 and 16. Numbers in parentheses indicate the position of the first amino acid in each sequence. The location of the
bipartite nuclear localization signal (NLS) is indicated by a double-arrow and highlighted in yellow. The nuclear export signal (NES) is shaded in blue.
Aligned MAPK- and CDK-phosphorylation sites [S/T]-P, are colored in pink. (B, C) SiHa-tetON/CSII-TRE-tight-HA16E1 or CSII-TRE-tight-HA16E1
(S93A, S107A cells were infected for 48 hours with rAd16E1^E4 or rAdβ-Gal in the presence of 1 μg/ml of Doxycycline. Cells were stained for
16E1^E4 (green), 16E1 (red; HA-tag) and DNA (blue; DAPI) to show the increased nuclear distribution of wild type E1 but not the phosphorylation-
deficient E1 mutant (S93A, S107A) following co-expression with E4. (D) The number of cells showing E1-nuclear localization was quantified, and is
shown as a percentage of the total number of E1-positive cells counted amongst the E4-positive and E4-negative cells. Wild type E1, but not the
phosphorylation-deficient mutant, was enhanced in the presence of E4. The standard deviations of three independent sets of 1000 E1-positive cells
are indicated by the error bars. (E) To assess replication competence, plasmids expressing 16E1/E2/E4 or 16E1/E2 were transfected along with a
HPV 16 replication origin-containing plasmid (p16Ori) as described in the Materials and Methods (S6 Fig). Amplified p16Ori plasmid was analysed by
Southern blotting using extracted total DNA (upper panel). The levels of p16Ori input are shown in the lower panel. (F) Columns show quantitation
of the 72h Southern blot signal averaged across triplicate experiments. Data is shown as ‘fold’ change when compared to the level of replication
seen in the absence of E4. (G) As in (F) above, columns show the change in replication seen in the presence or absence of E4, but in this case, a
luciferase reporter plasmid system was used (see materials and methods and S6 Fig). Results were generated from the average of six independent
experiments.
https://doi.org/10.1371/journal.ppat.1006282.g008
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differentiated raft cultures was predominantly nuclear in our hands, although previous studies
have reported both nuclear and cytoplasmic E2 protein using this antibody [63]. In an attempt
to substantiate these observations, we next went on to examine E2 by western blotting (S7D,
S7E and S7F Fig), using the microdissection approach used previously to assess L1 accumula-
tion. E2 antibody specificity was first assessed against 16E2 expressed from endogenously
expressed E2 in 293T cells (S7D Fig), before being examined in organotypic raft extracts. The
results were broadly compatible with the immunofluorescence staining, and was reproducibly
seen in the replicate rafts prepared here (S7E and S7F Fig). Although we suspect that 16E4
most likely affects E2 function as well as E1, in the absence of more robust E2 detection
reagents and a better understanding of E2 MAPK phosphorylation, a contribution to the E1
recruitment to the viral origin of replication may be expected.
Given the above effects of 16E1^E4 on the viral replication proteins, and in particular its
effect on E1 nuclear localization, we next examined the contribution of 16E1^E4 on E1/
E2-mediated replication using the modified in vitro replication assay. In the first instance,
pIRES-16E1/E2/E4 and pIRES-16E1/E2 were transfected into monolayer C33a or SiHa cells
along with a HPV16 replication origin-containing plasmid (p16Ori [41]). Despite variation in
pOri input levels, E4 (pIRES-16E1/E2/E4) appeared to enhance E1/E2-mediated replication
efficiency (Fig 8E and 8F). To confirm these results, and to avoid the inaccuracies that can
result from the measurement of band intensities (see Fig 8E), a modified reporter plasmid was
prepared (p16Ori-CMV-GLuc (S6 Fig)), to allow replication efficiency to be estimated from
the Gluc/Cluc ratio after co-transfection with a pCMV-CLuc reporter plasmid. In this system,
the presence of 16 E4 reliably enhanced E1/E2-mediated replication success in repeat (6x)
experiments (Fig 8G).
When taken together, the above results suggest a mechanism by which 16E4-mediated
MAP kinase modulation facilitates replication success, and also predicts that genome amplifi-
cation, the activation of MAP kinase, and the accumulation of 16E4 should occur simulta-
neously during the late stages of the HPV16 life cycle. To establish whether this is indeed the
case, a quadruple stain was carried out to localize the sites of viral genome amplification (as
determined by fluorescence in situ hybridisation (FISH)) with E4, p-JNK and DAPI. In the
HPV16 WT rafts, a remarkable co-localisation of all three markers was apparent, with genome
amplification occurring only in cells showing positivity for cytoplasmic p-JNK that were also
positive for 16E4 (Fig 9, upper panel, arrowed). A much lower level of genome amplification
was seen in the E4KO rafts, in the absence of E4 in cells that were always negative for activated
cytoplasmic p-JNK (Fig 9, lower panel, arrowed). As expected, and in line with other reports,
it was not possible to detect E1 during the productive life cycle with available antibodies [64].
When taken together with our E4 in vitro expression studies, this data strongly supports the
idea that 16E4 acts to modulate the cellular environment during the late stage of infection via
the MAPK activation, and that this influence the activity and/or localisation of viral proteins
more directly involved in viral genome amplification.
Discussion
Conflicting data have been reported as to the role of E4 during the virus life cycle, especially in
its contribution to viral genome amplification amongst different HPV types [13, 20–22]. To
address this issue, and to examine the mechanistic roles of E4 during productive infection, we
have carried out a careful comparative analysis of E4’s role in genome amplification between
the two most important high-risk HPV types, HPV16 and 18. To do this, we made use of WT
and E4KO genomes maintained in an isogenic keratinocyte cell background in order to elimi-
nate variation between different keratinocyte pools and differentiation protocols. Experiments
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Fig 9. Viral genome amplification during the productive life cycle occurs in cell co-expressing both 16E1^E4 and activated cytoplasmic
JNK. (A) Raft sections derived from NIKS cells harboring HPV16 WT or E4KO genomes were analysed at day 14 post-differentiation by quadruple
staining for E1^E4 (green), p-JNK (red), nuclear DNA (magenta; DAPI, colour modified using imageJ) and HPV16 genomic DNA (blue, in situ
hybridization, colour modified using imageJ). Efficient viral genome amplification is confined to the staining for cytoplasmic E4 and cytoplasmic
phosphor-JNK-positive upper epithelial layers of WT rafts. In the E4KO rafts a lower level of genome amplification can occur in cells that are negative
for cytoplasmic phosphor-JNK. Such cells are typically in the upper p-JNK-staining layers and typically show only nuclear p-JNK staining. The dotted
lines indicate the position of the basal layer. Images were captured using a 10x objective. (B) Enlarged areas of the regions boxed in (A) to show the
E4/p-JNK patterns in cells known to be supporting HPV16 genome amplification.
https://doi.org/10.1371/journal.ppat.1006282.g009
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were carried out using matched cell population harboring WT and E4KO genomes of either
HPV16 or 18 at similar copy number and at similar passage. Finally, because the HPV life
cycle is critically dependent on the differentiation status of the infected host cell, effects on
viral genome amplification were examined using raft culture time course experiments rather
than at a single raft time point, with digital imaging being used to help determine the signifi-
cance of changes in patterns of gene expression. Using these approaches, we conclude that
while E4 can contribute to virus replication efficiency and life cycle completion, it is not essen-
tial for these events. In the isogenic NIKS background, loss of 16E4 was found to have a much
more marked effect on life-cycle-success than 18E4, allowing us to identify a role for 16E4’s G2
arrest function as well as its ability to modulate members of the MAPK family, most notably
JNK, which we show to be a prominent modification seen during natural HPV16 infection in
vivo. The elevation of p-JNK, which was not seen in HPV18, once again highlights differences
in the life cycles of high-risk viruses. For HPV16, it appears that E4, and its effects on MAPK
affect E1 nuclear localisation, and that in both transient replication assays and during epithelial
differentiation, that 16 enhances replication success as a result.
Previous reports have suggested that the loss of full length E4 may enhance the growth rate
in undifferentiated HPV18-containing primary foreskin keratinocytes [21], possibly because
the over-expression of 18E4 in monolayer culture can cause cell cycle arrest at G2/M. The
growth rate of WT or E4KO genome-containing NIKS populations in our system were compa-
rable (Fig 1), which fitted with our observation that E4 is not detectable in undifferentiated
monolayer cell culture, either by immunostaining or western blotting, and is unlikely to dis-
rupt cell-cycle progression at G2. By contrast, high-level expression of the E4 protein of several
types, including HPV16 and 18 induces cell cycle arrest at G2/M in monolayer-cultured cells
[15, 16]. During the HPV life cycle, the expression of the E4 protein is controlled by the HPV
late promoter (p670 in HPV16, p811 in HPV18), which is driven by the epithelial differentia-
tion machinery. Although not always apparent, differentiation can occur to some extent in
keratinocyte monolayer culture post confluence, which may have contributed to the previous
observation [21]. In our hands using NIKS, we find that the presence of HPV16 or 18 episomal
genomes is a strong suppressor of differentiation in monolayer culture, with E4 expression not
apparent over the time course of our experimental growth assays. Given that we also saw no
effect of E4-loss on either epithelial thickness or the extent of cell cycle entry in raft culture, we
do not feel that E4 has any obvious role during the early stages of either the HPV16 or 18 life
cycles. A similar conclusion was reached when E4 loss was assessed in the CRPV model of
infection in vivo [44].
Although the loss of E4 delays viral genome amplification in both HPV16 and HPV18, the
effect was much more dramatically seen with HPV16. This allowed us to examine specific E4
functions in the context of the HPV16 life cycle, especially in viral genome amplification. In
repeat experiments, our stringent analysis showed that the loss of the G2-arrest motif in
HPV16 leads to a noticeable and consistent reduction in genome amplification success, sug-
gesting that G2 arrest function of E4 in HPV16 contributes to viral genome amplification effi-
ciency. In HPV-induced lesions or in HPV containing raft tissues, E4 expression starts before
E6/E7 levels decline [29], with the expression of these proteins overlapping in the middle epi-
thelial layers where viral genome amplification occurs [7, 29]. The G2 arrest function of E4 is
thought to suppress E7-mediated cell proliferation in the upper epithelial layers and to prolong
the G2-like state that is required for efficient viral genome amplification (reviewed in [45]).
From our results, this hypothesis remains reasonable for HPV16. There is however some
uncertainty regarding the role of E4 mediated G2-arrest in the life cycle of HPV18. Disruption
of a motif required for G2/M arrest in the E4 ORF of HPV18 genomes did not affect HPV18
genome amplification [47]. Although we have not tested the effect of the G2 arrest function of
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E4 on genome amplification in HPV18 in our system, in our raft culture time course experi-
ment, a reduction in genome amplification was seen only at early time points with the HPV18
E4KO mutant, and was not apparent at late time points. The expression pattern of E4 is similar
between the HPV16 and 18 WT, which may suggest that the G2 arrest function of HPV18 E4
may sometimes contribute to HPV18 genome amplification efficiency as seen here with
HPV16. From our previous analysis of HPV gene expression in model system of disease [23]
and in clinical material [24, 29], we suspect that this may be apparent at epithelial sites where
there is some deregulation of E6/E7 expression rather than in the raft model, which for HPV18
(as well as HPV31 and 45) appears to be a model of well-ordered productive infection rather
than neoplasia. Raft culture does not however mimic the precise characteristics found during
in vivo infection, and we are not yet able to model the different epithelial sites where HPV18
naturally causes disease. The different abilities of HPV16 and HPV18 to complete their life
cycle in organotypic rafts does however suggest important differences in tropism, and that a
common cell type is unlikely to support the life cycles of different HPV types equally. Indeed,
this was an important consideration when deciding to carry out our evaluation of two HPV
types in an isogenic cellular background. Interestingly, although we were able to match geno-
mic copy number in the WT and E4KO cell populations and lines, the copy number of estab-
lished HPV-containing NIKS was always different in cell populations prepared using HPV16
and 18. It is clear from this that HPV16 and 18 have different regulation of maintenance repli-
cation in the isogenic NIKS background, again reflecting differences between these two
viruses.
It appears however that other functions of E4 can contribute to the enhancement of viral
genome amplification efficiency. This study suggests that 16E4’s contribution to viral genome
amplification efficiency may also involve the activation of MAPK (mitogen-activated protein
kinase). The MAPK super-family is composed of ERKs, JNK/SAPKs and p38 MAPKs [65]. In
HPV11 and HPV31, the E1 protein, a DNA helicase/ATPase involved in initiating viral DNA
replication, shuttles from the cytoplasm into the nucleus after phosphorylation by ERK and/or
JNK, and remains in the nucleus because of the presence of activated CDK1/2, which can
phosphorylate a CRM-1 dependent NES which inhibits E1 nuclear export, allowing an en-
hancement of viral DNA replication with appropriate timing during productive infection
(reviewed in [55]). The work presented here reveals that E4 loss in the context of the HPV16
genome results in a significant reduction in sustained ERK, JNK and p38 MAPK activity in the
upper layers of the epithelium, with these proteins being absent in genome amplifying cells in
the HPV16 E4KO raft tissues. In addition to this, activated JNK was found to be prominently
associated with HPV16 E1^E4 in the cytoplasm of cells supporting HPV genome amplifica-
tion, both in the WT HPV16 rafts, but also in low-grade cervical disease caused by HPV16. In
fact the patterns of E4 and JNK expression, and their correlation with vegetative viral genome
amplification were very similar in the HPV16 WT rafts and in the patient biopsies, which
strengthen both the significance of our observations, and our confidence in the NIKS organo-
typic raft system. Interestingly, our previous work indicated that HPV16 E1^E4 stimulated
JNK and CDK activity when expressed in SiHa cells [14, 49] and retained CDK1/cyclin com-
plex in the cytoplasm and induced G2 arrest. As mentioned above, both ERK and JNK activa-
tion are important for E1 phosphorylation, with E1 phosphorylation being important for viral
DNA replication. Like HPV11 E1, the HPV16 E1 protein sequence contains a consensus
MAPK docking domain that is essential for ERK, JNK and p38 MAPK binding [48, 66], and a
consensus cyclin binding motif (RxL). A plausible hypothesis therefore is that HPV16 E1^E4
may activate MAPK and CDKs to modulate E1 nuclear localization in order to facilitate viral
genome replication. The observations here, that HPV16 E1^E4 expression facilitates HPV16
E1 nuclear localization and that HPV16 E1 lacking conserved putative phosphorylation sites
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failed to localize in the nucleus, support the idea that 16E1^E4 can contribute to viral genome
amplification by facilitating the unclear localization of E1 as a result of phosphorylation by
kinases such as MAPKs and CDKs activation. Interestingly, HPV16 E4 is also a target for self-
phosphorylation by activated MAPK, which occurs during viral genome amplification [18],
and which enhances the association with cytokeratin and E4 protein stability. This is thought
to trigger E4 protein accumulation, and prolong the G2 arrest period to facilitate optimal viral
genome amplification. Interestingly, a recent report has suggested that the phosphorylation of
E5 by activated p38 MAPK in HPV18 was important for viral genome replication (Tom Bro-
ker, University of Birmingham, Alabama, USA; personal communication). Our previous stud-
ies have shown that HPV16 E4 activates p38 MAPK directly as a result of an E4 triggered cell
stress response [49], and the results shown here, as well as those presented previously, suggest
E4 may also augment E5 and E2 function to some extent [61]. Interestingly, 16 E4 has been
reported to be able to bind and stabilise E2 in the cytoplasm [61], and just as with E1, the E2
protein can also be regulated by the cellular CDK1/2 kinases, which lead to an increase in E2
stability during S-phase [67]. In addition, E1^E4 and E5 are expressed together from an abun-
dant bicistronic viral transcript during the late stages of the virus life cycle, a pattern of expres-
sion that fits well with their possible functional association in stimulating and sustaining the
activity of MAPK. Clearly E4 has other roles during the late stages of infection, and our data
suggest that N-terminally cleaved E4, which assembles into E4 amyloid-like fibers, may acti-
vate p38 MAPK in the later stage of viral life cycle, with a potential role in virus transmission
and release (data presented here & [19], [49]). The extended p38 MAPK activation apparent in
the upper layers of HPV16 WT raft tissues supports this hypothesis. How E4 is associated with
ERK activation is not currently answered. Unlike pJNK, the level of phosphorylated pERK was
not changed when HPV16 E4 was expressed in SiHa cells by transfection with a 16E1^E4
expression vector or following rAd.16E1^E4 infection (data not shown). Indeed, ERK activa-
tion is thought to be mediated primarily by E7 and E5 [18]. Similarly, the co-expression of E2
and E4 did not alter ERK activation (data not shown), although the E4/E2 association reported
previously led to E2 stabilization [61], at least in the SiHa model. For JNK MAPK, we suspect
that 16E4 role may be to sequester the kinase onto the abundant E4 amyloid structures, and
that in the upper epithelial layers, the role of E6, E7 and E5 are critical for its presence. In this
case, some similarity is apparent with the prominent E4-mediated sequestration of CyclinB/
Cdk1 seen in lesions caused by Mu PV types such as HPV1, and Lambda papillomaviruses
such as the Canine or Rabbit Oral Papillomaviruses [14].
A key reason for initiating this study arose from the need to clarify whether E4 loss abol-
ishes genome amplification, or whether E4 acts to modulate amplification-efficiency but is not
essential for genome amplification per se. Our data demonstrate that loss of full length E1^E4
expression in HPV18 acts to delay differentiation-dependent viral DNA amplification and L1
expression. These data are slightly different from the previous report, which showed impaired
or abolished genome amplification and late gene expression in HPV18 E4KO. These differ-
ences may come from the different approaches used, and indeed our raft time course experi-
ments show that both conclusions could be reached depending on the time point analyzed.
Indeed, the culture of primary foreskin keratinocytes containing HPV18 WT and HPV18
E4KO genomes using the organotypic raft system, leads to similar results to those shown here
as culture times are extended, with both WT and mutant genomes producing similar infec-
tious titres (Craig Meyers, Penn State College of Medicine (personal communication)). Our
conclusions were facilitated by carrying out raft culture time course coupled with digital scan-
ning, which can reveal the different degree of epithelial differentiation and the relative changes
in protein expression. Poor genome amplification is always more apparent at early stages of
differentiation in the E4KO raft tissues, with raft time courses and differences in the time of
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analysis explaining many of the previous discrepancies. With HPV16, an abolition of genome
amplification is apparent at the early time point, whereas with the 18 rafts, it would looks as
though E4 has no effect on genome amplification if only the last time point is evaluated. These
are the two extremes. By looking at all the time points together we can get the clearest conclu-
sion that E4 acts generally to optimize replication efficiency, but is not essential for viral
genome amplification. To some extent, this conclusion may apply to all high risk HPV types,
although clearly the contribution of E4 is not uniform, and the sequestration of JNK in partic-
ular appears a characteristic of the HPV16 productive cycle. A different result was previously
reported during the low risk HPV11 life cycle, which may reflect the very different functions of
the low risk E6 and E7 genes, and the different ability of these proteins to drive cell prolifera-
tion. Interestingly, the ability of HPV18 to complete its life cycle in the absence of E4 in the
NIKS model, will allow us in future to consider the role of E4 in virus assembly, virus matura-
tion, and transmission, where the E4 proteins, including those of HPV16 and 18 almost cer-
tainly have their primary function.
When the data is taken together, we conclude that loss of full length E4 in HPV16 and 18
only delays viral genome amplification and L1 expression, but does not abolish these events in
the virus life cycle. For HPV16, this delay appears to be mediated by several of E4’s activities
including its G2 arrest function, and its role in activating members of the MAPK pathway,
such as ERK, JNK and p38, with sustained JNK activation being a HPV16-specific characteris-
tic that affects E1 nuclear localisation, and as a result of this, replication efficiency. Previous
studies showing effects of 16E4 on E2 stability and cytoplasmic accumulation [61], and the
cross-talk between 16E4 and E5-mediated kinase stabilisation most likely represent additional
E4-associated modifications involved in this process. The massive accumulation of E4 in the
upper epithelial layers, coupled with its ability to assemble into amyloid-like fibres, must how-
ever underlie an additional and perhaps more critical role for E4 post-genome amplification.
Supporting information
S1 Fig. HPV episomal status and genomic copy number in NIKS cell populations and
clonal cell lines. (A) Southern blot of DNA extracted from three HPV16 clonal cell popula-
tions (T1, T2 and T3) after digestion with Bam HI (B) and Hind III (H). The track labelled (-)
contains DNA extracted from the parental NIKS population. Hind III digestion allowed visual-
isation of mostly supercoiled (SC) viral genomic DNA, along with open circle (OC) and linear
(L) forms. Bam HI, which cuts once in the HPV16 genome, gave rise to a single 8kb linear
band (L). Bam HI-linearized HPV-16 control genomic DNA (tracks labelled ‘DNA’) was run
alongside DNA isolated from the clonal cell populations as a size marker. Slower-migrating
genomic DNA visible at higher loading is marked by an asterisk.
(B) To confirm that viral gene expression is primarily from episomal HPV, an APOT assay
was performed on the cell lines and cell populations used in this study. The clonal cell popula-
tions (T1,T2 and T3) shown in (A) express a predominant E6/E7 transcript of approximately
1Kb, whereas cell lines with integrated HPV DNA typically contain heterogeneous transcript
patterns comparable to those shown in track labelled ‘IN’. A ‘no RNA’ loading control is
shown in track (-).
(C & D) HPV copy number-diversity was established in 18 individual HPV16 (C) and HPV18
(D) clonal cell populations. While all cell lines harbored episomal genomes, the copy number
varied between individual clones, presumably reflecting copy number variation in individual
cells in the HPV16 and 18 populations. Copy number matched clones and populations were
used for the comparative analysis described here.
(TIF)
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S2 Fig. Transcripts spanning E1, E2, and the E1^E4 splice junction are expressed at similar
levels from both WT and E4KO genomes. (A) Viral transcripts spanning E1, E2, or using
the E1^E4 splice junction (880^3358), were quantified after reverse transcription (RT) by
qPCR as described in Materials and Methods. Transcript abundance was normalized against
total early transcripts measured using qPCR primers located immediately upstream of the
early polyadenylation site and within the E5 ORF (columns labeled E5). In the absence of the
RT step, the qPCR procedure produced negligible signal with all primer sets (mean 0.16%; SD
0.18%). No significant differences were apparent between the WT HPV16, the E4KO and
E4PIIP genomes, suggesting that the presence of E4 does not affect patterns of transcription.
(B) The ability of the E1^E4 primers to detect only the spliced E1^E4 transcript was assessed
against a 10-fold dilution series of cloned E1^E4 cDNA (orange crosses/line) or unspliced
HPV16 genomic DNA (blue crosses). The E1^E4 primers were amplified a PCR product only
from spliced cDNA.
(TIF)
S3 Fig. Organotypic rafts prepared using WT and E4KO genomes are not obviously compro-
mised in their ability to differentiate. (A) Rafts prepared using HPV16 WT or E4KO genomes
are shown at day 10 and day 14 after staining with Hemotoxylin and Eosin (H&E, upper panels).
The middle panels show immunofluorescence stains for E4 (green) and keratin 10 (K10, red),
with the lower panels showing staining for E4 (green) and filaggrin (red). Immunofluorescence
images are counterstained with DAPI (blue) to allow visualization of the cell nuclei.
(B) Rafts prepared using HPV18 WT or E4KO genomes and stained with H&E, or to establish
the patterns of K10 and filaggrin expression as described above.
(TIF)
S4 Fig. p38 MAPK phosphorylation in the presence or absence of 16E4 or 16E4ΔN. (A)
16E1^E4 was expressed from rAd16E1^E4 (tracks labelled E4+) in SiHa and SiHa_E5 cells
(tracks labelled E5+). SiHa_E5 cells have been described previously [18]. Levels of activated
p38 are shown in track labelled p-p38. The effects of 16E1^E4 on pERK1/2 in this system have
been described previously [18].
(B) The 16 E1^E4 protein or the N-terminally deleted form of 16 E1^E4 were expressed in
SiHa cells as described in Materials and Methods. Levels of activated p38 are shown in track
labelled p-p38.
(TIF)
S5 Fig. HPV 18E4 does not significantly contribute to p38 MAPK and ERK1/2 activity
during the HPV18 life cycle. (A) Raft tissues from NIKS containing HPV18 WT or E4KO
genomes were harvested at day 14 post-differentiation and stained for 18E1^E4 (green), phos-
pho-p38 MAPK (p-p38 MAPK) (red) and DNA (blue; DAPI). A modest elevation of p-p38
MAPK staining in the upper layers of the raft is apparent in rafts generated using the WT and
E4KO HPV18 genome with no significant differences between the two genomes. The dotted
lines indicate the position of the basal layer. Images were captured using a 10x objective.
(B) The extent and intensity of p-p38MAPK staining in the HPV18 WT and E4KO raft tissues
at the 14 day time-point post differentiation was digitally scanned from the basal layer to the
top of the raft tissue as described in the materials and methods. The expression of E4 in the
WT raft is shown as the grey shadow. A similar level of p-p38 MAPK activity was apparent
in the upper epithelial layers of rafts prepared using the WT and E4KO HPV18 genome.
(C) Raft sections from HPV18 WT or E4KO genomes were harvested at 14 days post-differen-
tiation and stained for 18E1^E4 (green), p-ERK1/2 (red) and DNA (blue; DAPI), to reveal dif-
ferences in the levels of ERK1/2 activity in the mid epithelial layers. The dotted lines indicate
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the position of the basal layer. Images were captured using a 10x objective.
(D) The extent and intensity of p-ERK1/2 staining in NIKS rafts harboring HPV18 WT or
E4KO raft tissues at day 14 was examined by digitally scanning the raft tissue from the basal
layer to the top of the raft. The distribution and intensity of E1^E4 staining in the WT raft is
shown as a grey shadow. In contrast to HPV16, 18E1^E4 had little effect on ERK1/2, which
was largely confined to the mid epithelial layers.
(TIF)
S6 Fig. pIRES-16E1/E2/E4 and pIRES-16E1/E2 gene expression plasmids. (A) Schematic
representation of the E1/E2/E4 and the E1/E2 expression vectors (pIRES-16E1/E2/E4 and
pIRES-16E1/E2). DNA fragment containing intact E1, E2 and E4 genes, or the E1 and E2
genes along with the E4KO gene, were cloned downstream of the CMV promoter in pIRE-
SeGFP. The E4 ORF is contained within the E2 ORF but is translated in different reading
frame from a sliced mRNA. The GFP protein is translated from the same transcripts using an
internal ribosome entry sites (IRES).
(B) Viral transcripts spanning E1, E2, or using the E1^E4 splice junction (880^3358), were
quantified after reverse transcription (RT) by qPCR as described in Materials and Methods. As
shown above, the ratio of transcripts spanning E1 or E2, or using the E1^E4 splice junction,
were similar to that seen from the HPV16 WT or E4KO genomes (S2 Fig).
(C) C33a cells were transfected with pIRES-16E1/E2/E4 or pIRES-16E1/E2. Cell extracts were
analyzed by Western blotting with antibodies to E2, E4, tublin and GFP. In the absence of
good E1 antibodies, E1 expression was visualized by RT-PCR as described in (B) above.
(D) The structure of the p16 Origin plasmid (p16Ori) and the p16Ori reporter plasmids (GLuc
and CLuc) are shown diagrammatically. These plasmids were used in the replication assays
shown in Fig 8.
(TIF)
S7 Fig. E2 is stabilized in the presence of E4. (A) Detection of E2 in HPV16 WT and E4KO
rafts and correlation with E4 expression. E2 staining was carried out using the rabbit poly-
clonal antibody described in [35] without purification. Although some background staining
was apparent with this antibody, nuclear staining, which overlapped the DAPI signal, was seen
in cells positive for E4 (arrowed). Such staining was always less distinct in the 16 E4KO raft.
(B) Enlarged image of cells arrowed to show the E2 (red) and E4 (green) immunofluorescence
staining in the mid epithelial layers of the 16E4WT raft.
(C) Digital imaging revealed a lower overall E2 signal, particularly in the mid-epithelial layers,
when 16E4WT and E4KO rafts were compared.
(D) Total protein extracted from 293T cells transfected with either empty or HPV16 E2 ex-
pression vector are shown in tracks labelled (-) and E2, following Western blotting using the
E2 rabbit polyclonal antisera described in [35].
(E) Total protein was extracted from microdissected raft epithelium (WT or E4KO) at the 14
day time point, and the levels of E2 protein visualised by Western blotting as in (D).
(F) Columns show quantitation of the Western blot signal averaged across triplicate experi-
ments and normalized to GAPDH. Data is shown as ‘fold’ change when compared to the E2
levels observed in the presence of E4.
(TIF)
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